Plasmablastic Lymphoma: Clinical Trials

1 trial for Plasmablastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Plasmablastic Lymphoma: new trials by email Literature Review of Plasmablastic Lymphoma trials Research Report on Plasmablastic Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Cyclophosphamide, Daratumumab, Doxorubicin - Plasmablastic Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma
Early Phase 1RecruitingAIDS Malignancy Consortium152021-05-242026-10-28

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Prednisone (1)  ·  Vincristine (1)  ·  daratumumab (1)  ·  deltacortene (1)  ·  prednylidene (1)

Sponsors

AIDS Malignancy Consortium (1)

Countries

United States (1)

Top investigators

Ariela Noy, MD (1)

NIH funding

UM1CA121947 (1)